Bibliografie tematiche / Gemfibrozilo

Indice

  1. Articoli di riviste
  2. Tesi
  3. Libri
  4. Capitoli di libri
  5. Atti di convegni

Letteratura scientifica selezionata sul tema "Gemfibrozilo"

Autore: Grafiati
Pubblicato: 4 giugno 2021
Ultima modifica: 6 febbraio 2022

Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili

Scegli il tipo di fonte:

Consulta la lista di attuali articoli, libri, tesi, atti di convegni e altre fonti scientifiche attinenti al tema "Gemfibrozilo".

Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.

Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.

Articoli di riviste sul tema "Gemfibrozilo"

1

Maguiña, Elbis, Fernando Nuevo V., and Jesús Rumiche B. "Análisis costo-efectividad del uso de estatinas frente a gemfibrozilo en pacientes de consultorios externos del Centro Médico Naval: "Cirujano Mayor Santiago Tavara"." Ciencia e Investigación 9, no. 1 (2006): 33–40. http://dx.doi.org/10.15381/ci.v9i1.5090.

Testo completo
Abstract (sommario):
El objetivo de la investigación fue determinar y comparar el costo-efectividad de Atorvastatina 20 mG y Pravastatina 20m mG trente a Gemfibrozilo 600mG, en el tratamiento de hiperlipidemia, e identificar los factores de riesgo. Fue un estudio transversal, descriptivo y retrospectivo, realizado en el Centro Médico Naval, en el período de enero de 2002 a julio de 2005. Se revisaron historias clínicas de 64 pacientes hiperlipidémicos, entre 40 y 64 años, que acuden a los consultorios externos de Cardiología, Endocrinología, Geriatría y Medicina Interna a quienes se les prescribió: Estatinas 20 mg
Gli stili APA, Harvard, Vancouver, ISO e altri
2

García Llopis, Paula, Alejandra González D’huicque, and Vicente Palop Larrea. "Edema facial por gemfibrozilo." Medicina Clínica 135, no. 8 (2010): 384. http://dx.doi.org/10.1016/j.medcli.2009.06.040.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
3

Acuña Elvira, Nerea. "Consulta farmacéutica: intoxicación por gemfibrozilo." Farmacéuticos Comunitarios 9, no. 2 (2017): 49–51. http://dx.doi.org/10.5672/fc.2173-9218.(2017/vol9).002.06.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
4

Tormo Molina, J., I. Gázquez Pérez, and A. Matas Hoces. "Cerivastatina y gemfibrozilo: una combinación peligrosa*." Atención Primaria 28, no. 6 (2001): 438–39. http://dx.doi.org/10.1016/s0212-6567(01)70410-6.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
5

de Arriba Méndez, José-Javier, Elena Gómez Merino, José Antonio Sáez Barcelona, and Lourdes Sáez Méndez. "Rabdomiólisis grave asociada a cerivastatina y gemfibrozilo." Medicina Clínica 117, no. 7 (2001): 278–79. http://dx.doi.org/10.1016/s0025-7753(01)72086-6.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
6

Bosch Rovira, T., J. A. Llompart Pou, and J. Forteza-Rey. "Rabdomiólisis asociada al tratamiento combinado con cerivastatina y gemfibrozilo." Revista Clínica Española 201, no. 12 (2001): 731–32. http://dx.doi.org/10.1016/s0014-2565(01)70966-6.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
7

Vascónez Espinosa, F., N. Gómez Rodríguez, A. Martín Joven, and F. J. Posada García. "Rabdomiólisis complicada con insuficiencia renal aguda en un paciente tratado con gemfibrozilo y cerivastatina." Revista Clínica Española 201, no. 4 (2001): 228–29. http://dx.doi.org/10.1016/s0014-2565(01)70806-5.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
8

Alean Flórez, Joel, Daniela Márquez Méndez, Saudith María Burgos Núñez, Germán Enamorado-Montes, and José Marrugo Negrete. "Productos farmacéuticos y de cuidado personal presentes en aguas superficiales, de consumo humano y residuales en el departamento de Córdoba, Colombia." Revista de Investigación Agraria y Ambiental 12, no. 2 (2021): 179–97. http://dx.doi.org/10.22490/21456453.4231.

Testo completo
Abstract (sommario):
Contextualización: gracias al avance de técnicas analíticas sensibles desarrolladas en las últimas décadas, se ha podido identificar y cuantificar la presencia de diversos contaminantes en el medio acuático, dentro de este grupo se encuentran los contaminantes emergentes (CE) conformados por productos de cuidado e higiene personal, antibióticos, hormonas, plastificantes, fármacos y otros que son vertidos a las fuentes de agua alterando el equilibrio de estos ecosistemas. 
 
 Vacío de investigación: diversas investigaciones muestran que los contaminantes emergentes pueden comprometer
Gli stili APA, Harvard, Vancouver, ISO e altri
9

Jiménez-Bambague, Eliana M., Carlos A. Madera-Parra, and Enrique J. Peña-Salamanca. "Eliminación de compuestos farmacéuticos presentes en el agua residual doméstica mediante un tratamiento primario avanzado." INGENIERÍA Y COMPETITIVIDAD 22, no. 1 (2020): 10. http://dx.doi.org/10.25100/iyc.v22i1.8794.

Testo completo
Abstract (sommario):
Se evaluó la presencia de compuestos farmacéuticos de los grupos terapéuticos antiepilépticos, agentes hipolipemiantes, analgésicos antiinflamatorios y tranquilizantes en tres jornadas de muestreo, además se estimó la eficiencia de eliminación mediante un tratamiento primario avanzado (TPA) con procesos de coagulación, floculación y sedimentación en la planta de tratamiento de agua residual de la ciudad de Cali (Colombia). De los compuestos medidos, 10 estuvieron por encima del límite de detección de la técnica analítica usada: carbamazepina, 10,11-Dihidro-10,11-dihidroxicarbamazepina, gabapen
Gli stili APA, Harvard, Vancouver, ISO e altri
10

Martín-Navarro, Juan Antonio, Vladimir Petkov-Stoyanov, María José Gutiérrez-Sánchez, and Luis Pedraza-Cezón. "Fracaso renal agudo por nefritis intersticial aguda con síndrome de Fanconi en relación con metamizol y gemfibrozilo." Nefrología 36, no. 3 (2016): 321–23. http://dx.doi.org/10.1016/j.nefro.2015.06.022.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
Più fonti

Tesi sul tema "Gemfibrozilo"

1

Breña, Figueroa Mirtha Rocío. "Diseño y desarrollo de una formulación para Gemfibrozilo 600 mg. tableta recubierta." Bachelor's thesis, Universidad Nacional Mayor de San Marcos, 2005. https://hdl.handle.net/20.500.12672/2603.

Testo completo
Abstract (sommario):
En el presente trabajo se han evaluado tres formulaciones para Gemfibrozilo 600 mg tableta recubierta, una realizada por compresión directa y dos por granulación húmeda, de las cuales se ha seleccionado a la formulación que cumple los parámetros establecidos para el dosaje, disolución y los factores de deferencia (F1) y similitud (F2), estos factores fueron determinados a través de la comparación por perfil de disolución con respecto al producto innovador. Se realizó el estudio de estabilidad acelerada (40ºC ± 2 ºC / 75% de humedad relativa ± 5%.), estabilidad a largo plazo (25 ºC ± 2 ºC / 60
Gli stili APA, Harvard, Vancouver, ISO e altri
2

Maguiña, Cacha Elbis Jhon, and Verástegui Diocelino Fernando Nuevo. "Análisis costo-efectividad del uso de estatinas frente a gemfibrozilo en pacientes de consultorios externos del Centro Médico Naval : Cirujano Mayor Santiago Távara." Bachelor's thesis, Universidad Nacional Mayor de San Marcos, 2006. https://hdl.handle.net/20.500.12672/2326.

Testo completo
Abstract (sommario):
El presente es un estudio transversal, descriptivo y retrospectivo realizado en el Centro Médico Naval “Santiago Távara”, ubicado en Av. Venezuela s/n Bellavista-Callao, con el objetivo de determinar y comparar el costo-efectividad de Estatinas (Atorvastatina 20mg y Pravastatina 20 mg) frente a Gemfibrozilo 600 mg en el tratamiento de hiperlipidemia durante el período de enero 2002 a julio 2005. Se revisaron las historias clínicas de 64 pacientes hiperlipidémicos, con edades entre los 40 y 64 años de ambos sexos que acuden a los consultorios externos de Cardiología, Endocrinología, Geriatría y
Gli stili APA, Harvard, Vancouver, ISO e altri
3

Hemingway, Cheryl Joy. "Investigation of the molecular mechanisms of inhibition of hepatic fatty acid and cholestral biosynthesis by hypolipidaemic agents." Thesis, University College London (University of London), 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.285489.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
4

Chamouret, Sandrine. "Le gemfibrozil : étiologie possible de pneumopathies médicamenteuses : à propos de deux cas." Saint-Etienne, 1995. http://www.theses.fr/1995STET6222.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
5

Prindiville, John S. "Circulating lipoproteins and tissue lipids: Effects of gemfibrozil on lipid metabolism in rainbow trout." Thesis, University of Ottawa (Canada), 2010. http://hdl.handle.net/10393/28555.

Testo completo
Abstract (sommario):
Lipids support crucial functions in teleost fish, including the production of energy; lipoproteins support the movement of lipids through the vascular system. The objective of this thesis was to determine if gemfibrozil (GEM), a mammalian PPARalpha agonist pharmaceutical, could alter the circulating lipoproteins and tissue lipid metabolism in the rainbow trout, Oncorhynchus mykiss. Injections of GEM lowered the concentration of lipoproteins and changed their size distribution, lipid and fatty acid content. These changes were associated with an increased lipoprotein lipase transcript level but
Gli stili APA, Harvard, Vancouver, ISO e altri
6

Santos, Tiago André Azevedo dos. "Fish personality, memory and learning hability: the effect of pharmaceuticals and abiotic factors." Master's thesis, Universidade de Aveiro, 2017. http://hdl.handle.net/10773/22023.

Testo completo
Abstract (sommario):
Mestrado em Biologia Molecular e Celular<br>Over the last years, animal personality has been gaining a lot of attention from the scientific community, and, at the moment, it is being questioned its importance in survival and the evolution of species in stress situation. Between all of potential stress agents, there are emerging environmental contaminants, such as, pharmaceuticals. However, there are not many behavior and personality studies in fish. The present work aims to increase the knowledge of how factors associated with personality can influence the response to pharmaceuticals detected
Gli stili APA, Harvard, Vancouver, ISO e altri
7

Filho, José Joaquim Fernandes Raposo. "Suco de laranja tem efeito sinérgico à estatina e ao genfibrozila no tratamento da aterosclerose." Universidade de São Paulo, 2010. http://www.teses.usp.br/teses/disponiveis/5/5131/tde-22092010-162733/.

Testo completo
Abstract (sommario):
FUNDAMENTO: O suco de laranja (Citrus sinensis) é rico em vitami-na C, folatos e seu principal flavonóide, a hesperidina, cuja conformação es-pacial é semelhante à genisteína de soja que tem ação favorável sobre o aparelho cardiovascular. A vitamina C é conhecida como potente inibidor da peroxidação lipídica. Mas sua capacidade por possuir efeitos terapêuticos no tratamento da aterosclerose é pouco estudada. OBJETIVO: O presente tra-balho visa a determinar se o suco de laranja pode ter efeito aditivo no trata-mento com estatinas e fibratos, reduzindo placas ateroscleróticas e a quanti-dade de
Gli stili APA, Harvard, Vancouver, ISO e altri
8

Laser, Eric [Verfasser], Olaf [Gutachter] Picker, and Georg [Gutachter] Flügen. "Der Einfluss von Gemfibrozil und Pravastatin auf die mitochondriale Funktion im Colon und in der Leber in vitro - Ein Therapieansatz bei Sepsis? / Eric Laser ; Gutachter: Olaf Picker, Georg Flügen." Düsseldorf : Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf, 2021. http://d-nb.info/1230135111/34.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
9

Bergman, Ebba. "The Hepatobiliary Transport of Rosuvastatin In Vivo." Doctoral thesis, Uppsala universitet, Institutionen för farmaci, 2009. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-109866.

Testo completo
Abstract (sommario):
In vivo studies of hepatobiliary disposition are challenging. The hepatobiliary system is complex, as its physiological localization, complex cellular structure with numerous transporters and enzymes, and the interindividual variability in protein expression and biliary flow will all affect the in vivo disposition of a drug under investigation. The research included in this thesis has focused on the involvement of hepatic transport proteins in the hepatobiliary disposition of rosuvastatin. The impact that several transport inhibitors had on the pharmacokinetics of rosuvastatin was investigated
Gli stili APA, Harvard, Vancouver, ISO e altri
10

Dah-Chung, Owe Yang, and 歐陽大中. "The Synthesis of Gemfibrozil." Thesis, 1994. http://ndltd.ncl.edu.tw/handle/75834394951751380638.

Testo completo
Abstract (sommario):
碩士<br>國立成功大學<br>化學工程研究所<br>82<br>2,2-dimethyl-5(2,5-xylyloxy) valeric acid, known as gemfibrozil, and used for treatment or prevention of arteriosclerosis, can be produced by these ways: (1) Abstraction of proton from Me2CHCOPh using NaNH2 followed by alkylation with Br(CH2)3Cl resulted in Cl(CH2)3CMe2COPh(b). Refluxing b with anhydrous K2CO3,KI and 2,5-xylenol in a medium polar solvent gave 2,5-Me2C6H3O(CH2)3CMe2COPh. The latter was heated with KOCMe3 in anisole to yield gemfibrozil. The r
Gli stili APA, Harvard, Vancouver, ISO e altri
Più fonti

Libri sul tema "Gemfibrozilo"

1

Sarma, Syam. The gemfibrozil cost-benefit model: Analysis of data from the Helsinki Heart Study, model development, and extension to the California Medicaid population. RAND, 1993.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
2

Sarma, Syam. The gemfibrozil cost-benefit model: Analysis of data from the Helsinki Heart Study, model development, and extension to the California Medicaid population. RAND, 1993.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
3

Sarma, Syam. The gemfibrozil cost-benefit model: Analysis of data from the Helsinki Heart Study, model development, and extension to the California Medicaid population. RAND, 1993.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
4

Sarma, Syam. The gemfibrozil cost-benefit model: Analysis of data from the Helsinki Heart Study, model development, and extension to the California Medicaid population. RAND, 1993.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
5

Sarma, Syam. The gemfibrozil cost-benefit model: Analysis of data from the Helsinki Heart Study, model development, and extension to the California Medicaid population. RAND, 1993.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
6

Wood, Clive. Further Progress With Gemfibrozil. Royal Society of Medicine, 1987.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
7

Publications, ICON Health. Gemfibrozil - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References. ICON Health Publications, 2004.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri

Capitoli di libri sul tema "Gemfibrozilo"

1

Ciuffetti, G., G. Orecchini, D. Siepi, G. Lupattelli, and A. Ventura. "Hemorheological Activity of Gemfibrozil in Primary Hyperlipidemias." In Drugs Affecting Lipid Metabolism. Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-71702-4_69.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
2

Giudici, G. A., F. Pagani, C. Selvini, P. Stefanoni, C. Di Santo, and C. Vergani. "Effects of Gemfibrozil on Lipoproteins in Patients with Dyslipoproteinemia." In Drugs Affecting Lipid Metabolism. Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-71702-4_67.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
3

Steiner, G. "Relationship of glucose intolerance and elevated triglyceride: implications for gemfibrozil." In Atherosclerosis and Cardiovascular Diseases. Springer Netherlands, 1987. http://dx.doi.org/10.1007/978-94-009-3205-0_28.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
4

Yoshida, Hiroshi, Makoto Ayaori, Tetsuya Hisada, Toshitsugu Ishikawa, Fumitaka Ohsuzu, and Haruo Nakamura. "Beneficial Effect of Gemfibrozil on LDL Chemicophysical Characteristics and Oxidizability." In Lipoprotein Metabolism and Atherogenesis. Springer Japan, 2000. http://dx.doi.org/10.1007/978-4-431-68424-4_17.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
5

Manzato, E., S. Zambon, R. Marin, G. Baggio, and G. Crepaldi. "Plasma Lipids, Lipoproteins, and Apoproteins During Gemfibrozil Treatment in Primary Hyperlipidemias." In Drugs Affecting Lipid Metabolism. Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-71702-4_66.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
6

Kashyap, M. L., and K. Saku. "HDL Deficiency, Atherosclerosis, and Stimulation of HDL Synthesis: Role of Gemfibrozil." In Drugs Affecting Lipid Metabolism. Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-71702-4_68.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
7

Barbara, L., G. Mazzella, N. Villanova, et al. "Effect of Gemfibrozil Administration on Biliary Lipid Secretion: A Crossover Study with Clofibrate." In Drugs Affecting Lipid Metabolism. Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-71702-4_65.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
8

Allhoff, Peter, Ulrich Laaser, and Joachim Heinrich. "Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle Aged Men with Dyslipidemia." In Kompendium der Lipid-Studien. Springer Berlin Heidelberg, 1991. http://dx.doi.org/10.1007/978-3-642-95642-3_30.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
9

Kashyap, Moti L., and Keijiro Saku. "HDL Metabolism in HDL Deficiency Associated with Familial Hypertriglyeridemia: Effect of Treatment with Gemfibrozil." In Hypercholesterolemia, Hypocholesterolemia, Hypertriglyceridemia, in Vivo Kinetics. Springer US, 1990. http://dx.doi.org/10.1007/978-1-4684-5904-3_28.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
10

van Tol, Arie, Juhani Kahri, Bernhard Eisele, Timo Sane, and Marja-Riitta Taskinen. "Gemfibrozil Increases Plasma Levels of Cholesterylester Transfer Protein (Cetp), But Lowers Cholesterylester Transfer in Hypertriglyceridemic Subjects." In Drugs Affecting Lipid Metabolism. Springer Netherlands, 1996. http://dx.doi.org/10.1007/978-94-009-0311-1_65.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri

Atti di convegni sul tema "Gemfibrozilo"

1

Benitta, T. Asenath, G. K. Balendiran, C. James, V. K. Vaidyan, and V. S. Jayakumar. "Vibrational Spectral Studies of Gemfibrozil." In PERSPECTIVES IN VIBRATIONAL SPECTROSCOPY: Proceedings of the 2nd International Conference on Perspectives in Vibrational Spectroscopy (ICOPVS 2008). AIP, 2008. http://dx.doi.org/10.1063/1.3046218.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
2

Laustiola, K., R. Lassila, P. Koskinen, and V. Manninen. "GEMFIBROZIL HAS ANTI-PLATELET EFFECTS IN PATIENTS WITH HYPERCHOLESTEROLAEMIA DURING PHYSICAL STRESS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643462.

Testo completo
Abstract (sommario):
Earlier studies indicate an increased platelet reactivity in patients with hypercholesterolaemia. Physical and mental stress have also been reported to cause increased reactivity. The present study was undertaken to evaluate the effect of gemfibrozil (G) a new lipid lowering drug on platelet reactivity during physical stress. Ten otherwise healthy male subjects with serum cholesterol levels above 7 mmol/l were involved in a double-blind study. It consisted of two treatment periods of 8 weeks during which the patients were given either G (600 mg b.i.d.) or placebo (PI) and an 8 weeks wash-out p
Gli stili APA, Harvard, Vancouver, ISO e altri
3

Liu, Yanghe, Chenguang Sheng, and George Agbai Nnanna. "Detection of Selected Pharmaceutical Contaminants and Removal Efficiency of Emerging Contaminants by Application of Membrane Filtration Technology." In ASME 2014 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2014. http://dx.doi.org/10.1115/imece2014-36906.

Testo completo
Abstract (sommario):
Removal of emerging contaminants is considered to be one of the most important processes within advanced Waste Water Treatment Plants (WWTPs) system. Pharmaceutical contaminants in drinking water could potentially lead to human’s increasing risks of heart attacks, organ damage, mental health and even cancer. This paper investigates the emerging contaminant removal efficiencies of technologies employed by local WWTPs. After determining the presence of selected emerging contaminants (17β-estradiol, Acetaminophen, Carbamazepine, Diclofenac, Erythromycin, Estrone, Bezafibrate, Fluoxetine, Gemfibro
Gli stili APA, Harvard, Vancouver, ISO e altri
4

Sheng, Chenguang, A. G. Agwu Nnanna, Yanghe Liu, and John D. Vargo. "Removal of Pharmaceutical Contaminants in Water." In ASME 2015 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2015. http://dx.doi.org/10.1115/imece2015-53240.

Testo completo
Abstract (sommario):
Pharmaceutical contaminants in drinking water could potentially lead to increasing risks of heart attacks, organ damage, mental health and even cancer. Because their presence, frequency of occurrence, or source may not be known, the chemicals being discovered in water that previously had not been detected or are being detected at levels that may be significantly different than expected. Removal of emerging contaminants is considered recently to be one of the most important processes within advanced Waste Water Treatment Plants (WWTPs) system. EPA is working to improve its understanding of a nu
Gli stili APA, Harvard, Vancouver, ISO e altri
Ti possono interessare anche gli elenchi estesi di opere sul tema "Gemfibrozilo":
Articoli di riviste Tesi
Offriamo sconti su tutti i piani premium per gli autori le cui opere sono incluse in raccolte letterarie tematiche. Contattaci per ottenere un codice promozionale unico!

Vai alla bibliografia